Clinical Trials Directory

Trials / Terminated

TerminatedNCT02436356

New Tools for Assessing Fracture Risk

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
48 (actual)
Sponsor
Vanderbilt University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to determine whether two new, non-X-ray techniques can discriminate between high-energy fractures of normal bone (trauma) and low-energy fractures (fragility) of osteoporotic bone. The current gold-standard for assessing fracture risk areal bone mineral density (aBMD) by dual energy X-ray absorptiometry (DXA) is not particularly effective at identifying individuals who are at risk of suffering a fracture. Yet, there is a growing population of diabetics and elderly individuals prone to fractures. In effect, the age-related and diabetes-related increase in fracture risk is independent of a person's aBMD. These findings stress the urgency in developing diagnostic tools that can improve fracture risk prediction so that patients can be treated with the appropriate anti-fracture therapies.

Conditions

Interventions

TypeNameDescription
DEVICEOsteoprobe-Reference Point Indentation (RPI)Diagnostic tool used for bone indentation to measure the ability of the tissue to resist microindentation (bone mineral strength).
RADIATIONDual-energy X-ray absorptiometry (DXA) ScansAssessment of Fracture Risk
RADIATIONMRIDetermines bound water and pore water of bone.

Timeline

Start date
2015-06-30
Primary completion
2018-05-23
Completion
2018-11-08
First posted
2015-05-06
Last updated
2020-11-02
Results posted
2020-10-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02436356. Inclusion in this directory is not an endorsement.